Article · 31 Mar 2025
Conference abstractPublished 2017
Neuroprotective insights of isorhamnetin against amyloid β(25-35)-induced oxidative insult and neuronal degeneration in rodent model: Perspectives on future therapeutics for Alzheimers disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The amyloid-Ã?² (AÃ?²) is the major protein component of brain senile plaques in AlzheimerâÂ?Â?s disease (AD) and is known to be directly responsible for the production of free radicals toxic to brain tissue. The present study was designed to elucidate the neuroprotective effect of Isorhamnetin (IRN), a flavone aglycones against the pathogenesis of AD. Experimental AD in rats was produced by intracerebroventricular administration of AÃ?² (25-35) peptide. Employing the following strategies of neurobehavioral, biochemical, immunohistochemistry, docking and molecular approach, we explored the attenuating effects of IRN against AÃ?² (25-35) peptide induced hippocampal neuronal loss and memory impairment. The present study has proven that IRN also reduced the expression of BACE-1 via inactivation of GSK3Ã?² and NFÃ?ºB inhibition thereby inhibiting the accumulation of AÃ?². Furthermore, IRN up regulated the phosphorylated GSK-3Ã?² and down regulated the expression of phosphorylated P-38 thereby inhibiting the Nrf-2 ubiquitination and improved the nuclear translocation of Nrf-2 which subsequently alleviated the expression of inflammatory cytokines which further reduced the ROS and RNS generation. Considering all the results, it can be suggested that IRN not only acts via antioxidant and anti-inflammatory activity but also by modulating the expression and function of AD related proteins. Hence, an amalgamation of in vivo, in vitro and in silico evidence might be supportive to delineate the neuroprotective potentials of IRN in the therapy of AD.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Neurology & Neurophysiology.
Conference abstract · 3 Feb 2025
The Most common cause of falls without cause in geriatric patients
Conference abstract · 3 Feb 2025
Neuroimaging by Evaluation Nerverenovate and Neuroplasticity of Acupuncture in Children with Cerebral Palsy
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neurology & Neurophysiology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Thangarajan Sumathi”
